Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

15/11/2018 The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) 26/07/2017 Guidance to develop individual dose recommendations for patients on chronic hemodialysis 17/03/2015 Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement 17/09/2014 Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology 14/08/2013 Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials 20/06/2013 Guidelines for submitting adverse event reports for publication

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More